Takeda Pharmaceutical Co Sees FY2026 Adj EPS $3.01; Sees Sales $29.585B

Benzinga Newsdesk www.benzinga.com Neutral 92.8%

Neg 0% Neu 92.8% Pos 0%

Takeda Pharmaceutical Co (NYSE:TAK) is looking for FY2026 Adj EPS of $3.01. sees sales of $29.585 billion.

Comments

No comments yet. Be the first!